Stay updated on Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial

Sign up to get notified when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.1%
    Check dated 2024-09-04T03:32:21.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    New terms such as 'Terminated' and 'Lack of Efficacy' have been added, along with several new dates in August 2024, while previous statuses and dates from June 2024 have been removed.
    Difference
    1%
    Check dated 2024-08-28T01:55:42.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-13T22:09:51.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The website has been updated to version v2.10.0, adding 8 more conditions and 2 more interventions/treatments, while removing the previous version v2.9.7.
    Difference
    0.5%
    Check dated 2024-07-23T14:20:45.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T06:23:42.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the version of the content on the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T12:16:17.000Z thumbnail image

Stay in the know with updates to Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.